Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeJohnson & Johnson

      Johnson & Johnson

      JNJ Stock: Is it Appealing at a 52-Week Low?
      Trading Tips

      JNJ Stock: Is it Appealing at a 52-Week Low?

      March 1, 2023
      JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations 
      Uncategorized

      JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations 

      October 20, 2022
      Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?
      Investing News

      Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

      October 19, 2022
      JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.
      Investing News

      JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

      October 10, 2022
      Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot
      Investing News

      Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot

      September 28, 2022
      Three Long Term Dividend Stocks to Buy
      Investing News

      Three Long Term Dividend Stocks to Buy

      September 15, 2022
      Johnson & Johnson (JNJ) Stock: A High-Value Dividend Stock
      Investing News

      Johnson & Johnson (JNJ) Stock: A High-Value Dividend Stock

      September 15, 2022
      Johnson & Johnson stock rose with the announcement of a $5 billion share buyback program and repeated profit targets.
      Investing News

      Johnson & Johnson stock rose with the announcement of a $5 billion share buyback program and repeated profit targets.

      September 14, 2022
      Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines 
      Investing News

      Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines 

      August 29, 2022
      Johnson & Johnson attempts to extend its “Texas two-step” in order to end talc litigation in two states
      Investing News

      Johnson & Johnson attempts to extend its “Texas two-step” in order to end talc litigation in two states

      August 22, 2022
      « 1 2 3 »

       

      LATEST NEWS

      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares
      • Investing News American Eagle Q3 2025 Earnings Report
      • Investing News CrowdStrike’s Strong Quarter Boosts Stock

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025